Omics-Insights: Your Weekly Genomics & Proteomics Digest

Greetings, Omics Enthusiasts!

Welcome to our latest Omics Newsletter, your gateway to the most recent updates and innovations from the dynamic world of genomics. In this edition, we bring you groundbreaking developments that are shaping the future of omics research. From transformative funding initiatives to revolutionary advancements in sequencing technologies and pioneering efforts in cancer diagnostics, our newsletter highlights the forefront of scientific progress. We also shine a spotlight on individuals and companies driving innovation in the field, including the remarkable work of Paul Steinberg and Lightcast, whose cutting-edge platform promises to revolutionize cellular biology. Additionally, don't miss out on exciting job opportunities in the omics domain and valuable insights on optimizing your LinkedIn profile for successful job hunting. Join us as we unravel the latest omics insights and explore the endless possibilities of genomic discovery.

This week's latest news in the field of Omics:

Synthetic Genomics Institute Receives €12 Million Funding from Carl Zeiss Foundation

Universit?t Heidelberg groundbreaking Synthetic Genomics Research Institute receives a substantial €12 million pledge from the Carl Zeiss Foundation. The forthcoming Carl-Zeiss-Stiftung Center for Synthetic Genomics will unite experts from Heidelberg University, the Karlsruhe Institute of Technology, and Johannes Gutenberg University Mainz in an interdisciplinary collaboration spanning various fields, from biology to data science. With a primary focus on leveraging artificial intelligence-driven methods to design synthetic DNA sequences, the institute aims to revolutionize biologics and biomaterials development. Michael Knop, deputy director of Heidelberg University's Center for Molecular Biology, highlights the coordinated efforts among research universities and anticipates significant advancements in synthetic genomics.

MGI and Eurofins Genomics Revolutionize Precision Health with Cutting-edge Sequencer Alliance

MGI Tech's collaboration with Eurofins Genomics Europe Genotyping A/S signifies a milestone in precision health initiatives across Europe. Through the acquisition of MGI's groundbreaking DNBSEQ-T20×2 ultra-high throughput sequencer and associated technologies, Eurofins Genomics aims to enhance accessibility to affordable sequencing for large-scale genome projects worldwide. The T20's exceptional throughput and cost-efficiency, powered by MGI's proprietary DNBSEQTM technology, herald a new era in genetic sequencing, with implications for scientific and clinical research.

Bruker Strengthens Portfolio with Acquisition of Phasefocus

Bruker's acquisition of Phasefocus Holdings Limited marks a significant advancement in optical cell imaging capabilities. By integrating Phasefocus' innovative label-free imaging microscope, Livecyte, into its portfolio, Bruker aims to amplify advancements in cell imaging across various domains. This strategic collaboration underscores Bruker's commitment to ongoing portfolio evolution and technological innovation.

Flomics Secures Funding for RNA-Based Multicancer Test Development

Flomics Biotech's successful seed financing round of €1.1 million paves the way for advancing the preclinical validation of its RNA-based liquid biopsy assay. With a focus on early detection of colorectal, lung, breast, prostate, and pancreatic cancer, Flomics aims to leverage next-generation sequencing technologies to revolutionize cancer diagnostics. Collaborations with clinical partners provide crucial support for advancing liquid biopsy development, with a focus on thorough validation and eventual market entry.

Neochromosome, Inc. Secures Contract for COVID Surveillance Sequencing in New York City

Neochromosome's six-year contract valued at up to $57 million from New York City for COVID-19 surveillance sequencing underscores the company's pivotal role in public health initiatives. By conducting sequencing on swab samples obtained from COVID-19-positive patients, Neochromosome aims to provide comprehensive data to aid in the development of novel medications. This initiative highlights the importance of genomic surveillance in managing public health crises.

Wobble Genomics Ltd Raises ￡8.5M for RNA Sequencing Advancements

Wobble Genomics' successful funding round of ￡8.5 million signifies significant progress in advancing RNA sequencing technologies. With a focus on identifying nucleic acid biomarkers across various sectors, including pharmaceuticals and agriculture, Wobble Genomics aims to accelerate biotechnological innovations. The support from leading life science investors underscores the potential of its technology to unlock new applications and drive transformative discoveries in genomics.

Spotlight: Person of the Week - Spotlight: Paul Steinberg , Innovator at Lightcast

I am excited to shine a light on Paul and Lightcast, as they're featured by Illumina Ventures in their March Spotlight!

Based in Cambridge, England, Lightcast is disrupting the field of cellular biology with its groundbreaking benchtop instrument.

Their pioneering platform offers a transformative approach to unraveling the complexities of individual cells in diverse environments. By harnessing cutting-edge technology to manipulate minuscule droplets using precision light beams, Lightcast empowers researchers to observe real-time cellular responses and interactions at the single-cell level, unveiling invaluable insights into cellular behavior.

From streamlining drug discovery processes to propelling advancements in antibody development, Lightcast's technology holds the potential to make a significant impact on the biomedical research landscape. As an external observer, I'm thrilled to witness the transformative potential of Lightcast's platform in revolutionizing translational research and drug discovery endeavors.

Current Live Omics Roles at Kinetica:

Europe:

Global Product Manager – Genomic Platforms – Europe

Global Product Manager – Genomic Solutions – Europe

Field Application Specialist – Genomics Platforms – UK

Sales Manager – Spatial Biology – DACH

Machine Learning Engineer – NGS Platforms – Europe

North America:

Field Application Specialist – Spatial Biology – Northeast US

Sales Executive – AI Imaging Software - West Coast

Sales Executive – AI Imaging Software – Mid-West

Sales Specialist – Spatial Biology – Mid-Atlantic

VP of Product Management – Life Science Instruments

Optimize Your LinkedIn Profile Like Your CV: Job Hunting Tips from an Omics Specialist Recruiter

Consistency is key when updating your LinkedIn profile to mirror your CV. Ensure that the information on your profile aligns seamlessly with your resume, including job titles, dates of employment, and key responsibilities. Present yourself professionally with a clear and professional profile photo, and craft a compelling headline and summary that accurately showcase your expertise in omics, using relevant keywords to enhance search visibility. Highlight your key achievements, projects, and publications concisely, and customize your LinkedIn URL to make it easier for recruiters to find you online. Additionally, list your omics-related skills prominently, encourage colleague endorsements, and request recommendations from supervisors or mentors to add credibility to your profile.

Wrapping Up Another Omics-Insights:

this edition of our Omics Newsletter has highlighted significant advancements and collaborations shaping the landscape of genomics. From groundbreaking funding initiatives like the Carl-Zeiss-Stiftung Center for Synthetic Genomics to transformative acquisitions by companies like Bruker and Flomics Biotech's innovative cancer diagnostics, the field continues to witness remarkable progress. Notably, the role of genomic surveillance in public health, exemplified by Neochromosome's contract for COVID-19 sequencing, underscores the critical intersection of genomics and healthcare. Additionally, the spotlight on Lightcast and Paul Steinberg illuminates the potential for disruptive technologies to revolutionize cellular biology and translational research. As opportunities in omics-related roles continue to expand, optimizing one's LinkedIn profile becomes crucial, as highlighted by expert insights in job hunting. With ongoing developments fueling innovation and collaboration, the future of genomics appears promising and dynamic.

Thank you for embarking on a journey into the dynamic world of Omics with Kinetica! Explore the latest genomics job opportunities, stay informed with industry news, and indulge in insightful blogs at www.kinetica.co.uk. Your curiosity drives my commitment to relevant content, and I'm here to provide insights that fuel your scientific endeavors. Feel free to reach out with any questions or feedback. Wishing you ongoing inspiration and discovery in your scientific pursuits. Until next week, may your experiments yield groundbreaking results, and may your Omics journey remain as fascinating as the science itself!

?

?

?

?

?